US outlines bold goals for bioeconomy




- Mar 14
- 1 min
Pfizer acquires Seagen in $43bn deal


- Feb 21
- 2 min
Spoonful of technology


- Feb 9
- 1 min
Spotlight: December 2022–January 2023


- Feb 6
- 2 min
Eli Lilly improves cold chain capacity


- Jan 24
- 2 min
Fear for pharma growth prospects


- Jan 17
- 1 min
Genomics identified as most impactful pharma trend


- Jan 17
- 1 min
Pharma voted second most trusted industry in Britain


- Jan 13
- 1 min
Moderna becomes latest ABPI member


- Jan 12
- 2 min
HBA names 2023 Woman of the Year


- Jan 10
- 1 min
Potential blockbuster drug front runners highlighted


- Jan 10
- 1 min
ROI in R&D declines sharply in 2022


- Jan 6
- 1 min
RSV drug nirsevimab chases FDA approval


- Dec 20, 2022
- 2 min
Spoonful of technology


- Dec 13, 2022
- 1 min
Prescribing habits shift noted in IBD


- Dec 9, 2022
- 1 min
A new moonshot for rare diseases


- Dec 6, 2022
- 1 min
Spotlight: October-November 2022


- Nov 29, 2022
- 2 min
Landmark approval for first haemophilia B gene therapy


- Nov 29, 2022
- 1 min
Urgent need to boost trade for UK's life sciences, says ABPI


- Nov 15, 2022
- 2 min
2022 Access to Medicine Index reveals improvement


- Nov 15, 2022
- 2 min
Pharma's sustainability agenda centre stage in new ABPI report


- Nov 9, 2022
- 1 min
First paediatric pneumococcal vaccine approved for 10 years


- Nov 7, 2022
- 2 min
New climate action announced by pharma CEOs


- Nov 7, 2022
- 1 min
Global health agencies collaborate to ease Ebola outbreak


- Nov 7, 2022
- 1 min
Thermo Fisher sponsorship supports future STEM workforce


- Nov 4, 2022
- 2 min
Spoonful of technology


- Nov 2, 2022
- 2 min
Pfizer joins GSK in RSV success


- Oct 31, 2022
- 2 min
WHO calls for urgent collaboration to end TB


- Oct 27, 2022
- 1 min
Renewed focus on measles and rubella in Senegal


- Oct 20, 2022
- 1 min
Germany pledges new funds to tackle antibiotic resistance


- Oct 19, 2022
- 1 min
Spotlight: August-October 2022


- Oct 13, 2022
- 1 min
First RSV vaccine for older adults earns pivotal Phase 3 results


- Oct 13, 2022
- 1 min
Repurposing medicines toolkit launched


- Oct 7, 2022
- 1 min
Promising outlook for integrating young talent in pharma


- Oct 7, 2022
- 1 min
Pfizer-BioNTech assemble with the Avengers in COVID booster drive


- Sep 29, 2022
- 2 min
Historic moment in Alzheimer’s drug development


- Sep 29, 2022
- 2 min
Pharma R&D set to increase despite energy crisis


- Sep 27, 2022
- 1 min
Daiichi Sankyo in leukaemia treatment approval first


- Sep 27, 2022
- 1 min
Pfizer and Delix named HBA gender parity champions


- Sep 27, 2022
- 1 min
Moderna joins BIA as 500th member


- Sep 21, 2022
- 1 min
GSK and Microsoft tackle Nepal disease transmission


- Sep 7, 2022
- 1 min
First malaria vaccine granted WHO prequalification


- Aug 31, 2022
- 1 min
Roche makes moves in PCR technology


- Aug 31, 2022
- 2 min
Spoonful of technology


- Aug 17, 2022
- 1 min
Spotlight: June-August 2022


- Aug 11, 2022
- 2 min
Gilead fights monkeypox misinformation


- Aug 4, 2022
- 1 min
French Biotech set to make waves in cell therapy evolution


- Aug 4, 2022
- 1 min
Bayer in top spot for equality, diversity and inclusion


- Jul 29, 2022
- 1 min
Access win for HIV patients in sub-Saharan Africa


- Jul 29, 2022
- 1 min
EC extends vaccine label to tackle monkeypox